Mass spectrometry-based proteomics in reproductive medicine.
about
Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosisMass spectrometry-based proteomics for pre-eclampsia and preterm birthAn integrated approach based on multiplexed protein array and iTRAQ labeling for in-depth identification of pathways associated to IVF outcomeProteomics mapping of cord blood identifies haptoglobin "switch-on" pattern as biomarker of early-onset neonatal sepsis in preterm newbornsMetabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery.Proteomic analysis of childhood de novo acute myeloid leukemia and myelodysplastic syndrome/AML: correlation to molecular and cytogenetic analyses.The Use of Proteomics in Assisted Reproduction.The potential role of ORM2 in the development of colorectal cancer.Maternal serum protein profile and immune response protein subunits as markers for non-invasive prenatal diagnosis of trisomy 21, 18, and 13.Maternal serum serpin B7 is associated with early spontaneous preterm birth.Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner.Validation of serum biomarkers derived from proteomic analysis for the early screening of preeclampsia.Characterization of the myometrial transcriptome and biological pathways of spontaneous human labor at term.2D DIGE analysis of maternal plasma for potential biomarkers of Down SyndromeAcid ceramidase improves the quality of oocytes and embryos and the outcome of in vitro fertilization.Characterization of Visceral and Subcutaneous Adipose Tissue Transcriptome and Biological Pathways in Pregnant and Non-Pregnant Women: Evidence for Pregnancy-Related Regional-Specific Differences in Adipose Tissue.Identification and quantification of preterm birth biomarkers in human cervicovaginal fluid by liquid chromatography/tandem mass spectrometry.Amniotic fluid: the use of high-dimensional biology to understand fetal well-being.Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ)From global proteome profiling to single targeted molecules of follicular fluid and oocyte: contribution to embryo development and IVF outcome.A large network of interconnected signaling pathways in human ovarian follicles is supported by the gene expression activity of the granulosa cells.Comparison of sVCAM-1 and sICAM-1 levels in maternal serum and vaginal secretion between pregnant women with preterm prelabour ruptures of membranes and healthy pregnant women.Proteins in leaked amniotic fluid as biomarkers diagnostic for prelabor rupture of membranes.Characterization of visceral and subcutaneous adipose tissue transcriptome in pregnant women with and without spontaneous labor at term: implication of alternative splicing in the metabolic adaptations of adipose tissue to parturition.
P2860
Q28081831-04B9D7FB-9E2B-4583-8880-26E43260E52BQ28083761-E1F848EC-3432-4230-A6B6-11A5AAE672F7Q28534457-2E541904-E24E-45E4-88CF-3B167410619DQ28744089-F429A0B5-0F2E-4484-86DA-CCB900B1EB89Q30524877-F7AE90ED-A3D0-443A-BDFE-DFD7339330FCQ33659100-C13B7C14-CCD8-41FC-9BDB-8A74E869F020Q33770728-3C894023-F064-485F-822D-663E01879898Q34171477-838036E2-20A1-4AEB-9090-EA4FEAD5A509Q34570581-254F6B4C-FC04-42DF-8DDF-1B5597BF5392Q34624304-F8024FDB-BC49-4983-B514-A68DFFAC1867Q34816101-0A8E8BC9-4EB7-4A71-AE79-19ACDE866679Q34987751-3D3DE97A-9CA0-429D-9337-C6F60D817D37Q34989601-2AEFA452-086C-475B-A35C-EF41431CC7C7Q35298620-8AFB5F44-7A11-4A9C-B0F6-7BFAE49BCFBCQ35596069-A5E7976C-CAC3-40E6-9832-94F057011C1FQ35861003-BFDEA68A-62C2-495F-97BA-80C9DEC6FF96Q37311954-11132A18-FCA0-453D-BDDC-2991BDBB6B09Q37379783-E7DABE27-BCAC-43ED-AF60-A3A1032C5E13Q37414538-C9A8D6AC-9255-4C55-A0C3-EA4F4A3E7CB2Q38534137-1A82C547-EF91-4730-A8EC-A13B108571A2Q44361212-94556B88-1B2E-4FB1-97EF-821A1DB8D611Q47448900-21BAA7EB-F6B3-4807-9628-DE863904D218Q54583555-05EF2B2F-F1AB-419A-9459-FB4FBB2C095FQ55326781-E7440A4A-34B8-41BD-A74F-27C6B6E4DBFB
P2860
Mass spectrometry-based proteomics in reproductive medicine.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Mass spectrometry-based proteomics in reproductive medicine.
@en
Mass spectrometry-based proteomics in reproductive medicine.
@nl
type
label
Mass spectrometry-based proteomics in reproductive medicine.
@en
Mass spectrometry-based proteomics in reproductive medicine.
@nl
prefLabel
Mass spectrometry-based proteomics in reproductive medicine.
@en
Mass spectrometry-based proteomics in reproductive medicine.
@nl
P2093
P2860
P356
P1476
Mass spectrometry-based proteomics in reproductive medicine.
@en
P2093
Aggeliki Kolialexi
Ariadni Mavrou
George Spyrou
George Th Tsangaris
P2860
P304
P356
10.1002/MAS.20181
P577
2008-11-01T00:00:00Z